Literature DB >> 11146702

Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives.

J H Samet1, P Friedmann, R Saitz.   

Abstract

Individuals with alcohol and drug use problems may receive health care from medical, mental health, and substance abuse providers, or a combination of all three. Systems of care are often distinct and separate, and substantial opportunities for benefit to patient, provider, and payer are missed. In this article, we outline (1) the possible benefits of linking primary care, mental health, and substance abuse services from the perspective of the major stakeholders-medical and mental health providers, addiction clinicians, patients, and society-and (2) reasons for suboptimal linkage and opportunities for improving linkage within the current health care system. We also review published models of linked medical and substance abuse services. Given the potential benefits of creating tangible systems in which primary care, mental health, and substance abuse services are meaningfully linked, efforts to implement, examine, and measure the real impact should be a high priority.

Entities:  

Mesh:

Year:  2001        PMID: 11146702     DOI: 10.1001/archinte.161.1.85

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  82 in total

1.  Designated case managers as facilitators of medical and psychosocial service delivery in addiction treatment programs.

Authors:  Peter D Friedmann; James C Hendrickson; Dean R Gerstein; Zhiwei Zhang
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

2.  Medical specialization, profession, and mediating beliefs that predict stated likelihood of alcohol screening and brief intervention: targeting educational interventions.

Authors:  Ruth A Gassman
Journal:  Subst Abus       Date:  2003-09       Impact factor: 3.716

3.  Trends in comprehensive service availability in outpatient drug abuse treatment.

Authors:  Peter D Friedmann; Stephenie C Lemon; Elizabeth M Durkin; Thomas A D'Aunno
Journal:  J Subst Abuse Treat       Date:  2003-01

Review 4.  Linkages between clinical practices and community organizations for prevention: a literature review and environmental scan.

Authors:  Deborah S Porterfield; Laurie W Hinnant; Heather Kane; Joseph Horne; Kelly McAleer; Amy Roussel
Journal:  Am J Public Health       Date:  2012-06       Impact factor: 9.308

5.  Risk of mortality during four years after substance detoxification in urban adults.

Authors:  Richard Saitz; Jessie Gaeta; Debbie M Cheng; Jessica M Richardson; Mary Jo Larson; Jeffrey H Samet
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

6.  Treatment Needs of Driving While Intoxicated Offenders: The Need for a Multimodal Approach to Treatment.

Authors:  Jillian Mullen; Stacy R Ryan; Charles W Mathias; Donald M Dougherty
Journal:  Traffic Inj Prev       Date:  2015       Impact factor: 1.491

7.  Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial.

Authors:  D Max Crowley; Damon E Jones; Donna L Coffman; Mark T Greenberg
Journal:  Prev Med       Date:  2014-02-09       Impact factor: 4.018

8.  Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial.

Authors:  Richard Saitz; Debbie M Cheng; Michael Winter; Theresa W Kim; Seville M Meli; Don Allensworth-Davies; Christine A Lloyd-Travaglini; Jeffrey H Samet
Journal:  JAMA       Date:  2013-09-18       Impact factor: 56.272

9.  Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net.

Authors:  Jamie Suki Chang; Margot Kushel; Christine Miaskowski; Rachel Ceasar; Kara Zamora; Emily Hurstak; Kelly R Knight
Journal:  Subst Use Misuse       Date:  2016-10-18       Impact factor: 2.164

10.  Effect of primary medical care on addiction and medical severity in substance abuse treatment programs.

Authors:  Peter D Friedmann; Zhiwei Zhang; James Hendrickson; Michael D Stein; Dean R Gerstein
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.